QIAGEN N.V.: QIAGEN Launches CE-marked Version of QuantiFERON SARS-CoV-2 to Assess T-cell Response to COVID-19

Easy-to-use workflow can detect T-cell response early in the course of COVID-19 infection or following vaccination Detection of T-cells can provide vital insights that completes the picture

Related Keywords

Netherlands ,Frankfurt ,Brandenburg ,Germany ,John Gilardi ,Jean Pascal Viola ,Thomas Theuringer ,Phoebe Loh ,Exchange Commission ,Us Securities Exchange ,Frankfurt Prime Standard ,Senior Vice President ,Molecular Diagnostics Business Area ,Molecular Diagnostics ,Applied Testing ,Exchange Act ,Qiagen ,Aunches ,Arked ,Version ,Quantiferon ,Cars ,Ssess ,Fell ,Response ,Covid ,